Electroconvulsive therapy improves antipsychotic and somnographic responses in adolescents with first-episode psychosis - A case-control study

Schizophrenia Research

Volumn 137, Issue 1-3, 2012, Pages 97-103

  Zhang, Zhang Jin ^a,b   Chen, Yun Chun ^a   Wang, Hua Ning ^a   Wang, Huai Hai ^a   Xue, Yun Yun ^a   Feng, Shu Fang ^a   Tan, Qing Rong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adolescents; Electroconvulsive therapy (ECT); First episode psychosis; Polysomnography (PSG)

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; ELECTROCONVULSIVE THERAPY; FEMALE; HEADACHE; HOSPITAL PATIENT; HUMAN; HYPERACTIVITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OPTIMAL DRUG DOSE; POLYSOMNOGRAPHY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP; SOMNOLENCE; TREATMENT RESPONSE; TREMOR; XEROSTOMIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; POLYSOMNOGRAPHY; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SLEEP DISORDERS; SLEEP, REM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862819916     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.01.037     Document Type: Article

References (32)

1. Brousse G., Meary A., Blanc O., Lançon C., Llorca P.M., Leboyer M. Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia. Psychiatry Res. 2010, 179:12-18.
2. Chakrabarti S., Grover S., Rajagopal R. Electroconvulsive therapy: a review of knowledge, experience and attitudes of patients concerning the treatment. World J. Biol. Psychiatry 2010, 11:525-537.
3. Chaves M.P., Crippa J.A., Morais S.L., Zuardi A.W. Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder. J. Clin. Psychiatry 2005, 66:542-543.
4. Cohen D., Taieb O., Flament M., Benoit N., Chevret S., Corcos M., Fossati P., Jeammet P., Allilaire J.F., Basquin M. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am. J. Psychiatry 2000, 157:460-462.
5. Consoli A., Benmiloud M., Wachtel L., Dhossche D., Cohen D., Bonnot O. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics. J. ECT 2010, 26:259-265.
6. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for the Diagnostic and Statistical Manual 1997, patient version, American Psychiatric Press, Washington, DC. 4th ed.
7. Fraguas D., Correll C.U., Merchán-Naranjo J., Rapado-Castro M., Parellada M., Moreno C., Arango C. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur. Neuropsychopharmacol. 2011, 21:621-645.
8. Ghaziuddin N., Kutcher S.P., Knapp P., Bernet W., Arnold V., Beitchman J., Benson R.S., Bukstein O., Kinlan J., McClellan J., Rue D., Shaw J.A., Stock S., Kroeger Ptakowski K. Practice parameter for use of electroconvulsive therapy with adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:1521-1539. Work Group on Quality Issues; AACAP.
9. Ghaziuddin N., Dumas S., Hodges E. Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression. J. ECT 2011, 27:168-174.
10. Grunhaus L., Shipley J.E., Eiser A., Pande A.C., Tandon R., Krahn D.D., Demitrack M.A., Remen A., Hirschmann S., Greden J.F. Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy. Biol. Psychiatry 1997, 42:191-200.
11. Guy W. ECDEU Assessment Manual for Psychopharmacology (Revised) 1976, US Department of Health, Education, and Welfare, Bethesda, MD.
12. Hedges D., Jeppson K., Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc.) 2003, 39:551-557.
13. Heuyer G., Bour Field Electroshock in adolescents. Ann. Med. Psychol. 1942, 2:75-84.
14. Hulshoff Pol H.E., Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008, 34:354-366.
15. Kato N. Neurophysiological mechanisms of electroconvulsive therapy for depression. Neurosci. Res. 2009, 64:3-11.
16. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
17. Krystal A.D., Thakur M., Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann. Clin. Psychiatry 2008, 20:39-46.
18. Kutcher S., Robertson H.A. Electroconvulsive therapy in treatment resistant bipolar youth. J. Child Adolesc. Psychopharmacol. 1995, 5:167-175.
19. Masi G., Liboni F. Management of schizophrenia in children and adolescents: focus on pharmacotherapy. Drugs 2011, 71:179-208.
20. Masliah E., Crews L., Hansen L. Synaptic remodeling during aging and in Alzheimer's disease. J. Alzheimer's Dis. 2006, 9:91-99. Suppl.
21. Monti J.M., Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med. Rev. 2004, 8:133-148.
22. Mora F., Segovia G., del Arco A. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain Res. Rev. 2007, 55:78-88.
23. Nenadic I., Sauer H., Smesny S., Gaser C. Aging effects on regional brain structural changes in schizophrenia. Schizophr. Bull. 2011, Feb 4 [Epub ahead of print].
24. Nobler M.S., Sackeim H.A. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. J. ECT 2008, 24:40-45.
25. Remschmidt H., Theisen F.M. Schizophrenia and related disorders in children and adolescents. J. Neural Transm. Suppl. 2005, 69:121-141.
26. Rey J.M., Walter G. Half a century of ECT use in young people. Am. J. Psychiatry 1997, 154:595-602.
27. Schennach-Wolff R., Jäger M., Mayr A., Meyer S., Kühn K.U., Klingberg S., Heuser I., Klosterkötter J., Gastpar M., Schmitt A., Schlösser R., Schneider F., Gaebel W., Seemüller F., Möller H.J., Riedel M. Predictors of response and remission in the acute treatment of first-episode schizophrenia patients - is it all about early response?. Eur. Neuropsychopharmacol. 2011, 21:370-378.
28. Shoirah H., Hamoda H.M. Electroconvulsive therapy in children and adolescents. Expert Rev. Neurother. 2011, 11:127-137.
29. Squire L.R. ECT and memory loss. Am. J. Psychiatry 1977, 134:997-1001.
30. Srinath S., Kandasamy P., Golhar T.S. Epidemiology of child and adolescent mental health disorders in Asia. Curr. Opin. Psychiatry 2010, 23:330-336.
31. Taieb O., Flament M.F., Corcos M., Jeammet P., Basquin M., Mazet P., Cohen D. Electroconvulsive therapy in adolescents with mood disorder: patients' and parents' attitudes. Psychiatry Res. 2001, 104:183-190.
32. Tharyan P., Adams C.E. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst. Rev. 2005, 18(2):CD000076.